Lookup NU author(s): Emeritus Professor Elaine Perry,
Professor Ian McKeith,
Dr Clive Ballard
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Butyrylcholinesterase is implicated in the pathology of AD. Selective inhibitors increase acetylcholine and improve cognitive function in animal models. In dementia with Lewy bodies, cholinergic activities are more affected than in AD. The authors report a highly significant association between temporal cortex butyrylcholinesterase activity and the rate of cognitive decline in a prospectively studied, autopsy-confirmed dementia with Lewy bodies series.
Author(s): Perry E, McKeith I, Ballard C
Publication type: Article
Publication status: Published
ISSN (print): 0028-3878
ISSN (electronic): 1526-632X
Publisher: Lippincott Williams & Wilkins
PubMed id: 12796550